Last 12 months
Inside the activity.
1 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2019 Filed Mar 6, 2019 18:15 UTC |
Turitz AndrewSVP - Business Development
|
Tax withholdingCommon Stock | 846 | $67.55 | $57,147.30 |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,635 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:15 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 2,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003465 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:08 UTC |
Verstraete StephanyChief Marketing Officer
|
GrantRestricted Stock Units · Derivative | 11,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · derivative · entry 6 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,103 Underlying: Common Stock · 11,103 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:08 UTC |
Verstraete StephanyChief Marketing Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · derivative · entry 5 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,338 Underlying: Common Stock · 3,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:08 UTC |
Verstraete StephanyChief Marketing Officer
|
Tax withholdingCommon Stock | 1,035 | $67.55 | $69,914.25 |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:08 UTC |
Verstraete StephanyChief Marketing Officer
|
Exercise / conversionCommon Stock | 3,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:38 UTC |
MCCLENNEN PETER APresident
|
GrantRestricted Stock Units · Derivative | 17,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003475 · edgar.xml · derivative · entry 6 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,395 Underlying: Common Stock · 17,395 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F6 · derivative.exercise_date: The restricted stock unit vests in two equal annual installments beginning March 1, 2020. F6 · derivative.expiration_date: The restricted stock unit vests in two equal annual installments beginning March 1, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:38 UTC |
MCCLENNEN PETER APresident
|
GrantRestricted Stock Units · Derivative | 22,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003475 · edgar.xml · derivative · entry 5 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,206 Underlying: Common Stock · 22,206 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:38 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionRestricted Stock Units · Derivative | 8,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003475 · edgar.xml · derivative · entry 4 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,566 Underlying: Common Stock · 8,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 24,849 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 24,849 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:38 UTC |
MCCLENNEN PETER APresident
|
Tax withholdingCommon Stock | 7,310 | $67.55 | $493,790.50 |
DisclosureSEC source: 0001179110-19-003475 · edgar.xml · nonDerivative · entry 3 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,670 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:38 UTC |
MCCLENNEN PETER APresident
|
GrantCommon Stock | 8,697 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003475 · edgar.xml · nonDerivative · entry 2 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,980 F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:38 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionCommon Stock | 8,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003475 · edgar.xml · nonDerivative · entry 1 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:12 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
GrantRestricted Stock Units · Derivative | 10,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003464 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,363 Underlying: Common Stock · 10,363 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:12 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 3,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003464 · edgar.xml · derivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,491 Underlying: Common Stock · 3,745 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 11,236 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 11,236 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:12 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 3,745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003464 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC |
Cappucci Gabriel R.Senior VP, Controller and CAO
|
GrantRestricted Stock Units · Derivative | 4,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003461 · edgar.xml · derivative · entry 4 Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,441 Underlying: Common Stock · 4,441 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC |
Cappucci Gabriel R.Senior VP, Controller and CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003461 · edgar.xml · derivative · entry 3 Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,533 Underlying: Common Stock · 1,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 5,300 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 5,300 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC |
Cappucci Gabriel R.Senior VP, Controller and CAO
|
Tax withholdingCommon Stock | 538 | $67.55 | $36,341.90 |
DisclosureSEC source: 0001179110-19-003461 · edgar.xml · nonDerivative · entry 2 Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,229 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC |
Cappucci Gabriel R.Senior VP, Controller and CAO
|
Exercise / conversionCommon Stock | 1,767 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003461 · edgar.xml · nonDerivative · entry 1 Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC |
Levy LewisChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 7,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003460 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,402 Underlying: Common Stock · 7,402 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003460 · edgar.xml · derivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,762 Underlying: Common Stock · 2,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 8,643 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 8,643 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC |
Levy LewisChief Medical Officer
|
Tax withholdingCommon Stock | 972 | $67.55 | $65,658.60 |
DisclosureSEC source: 0001179110-19-003460 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F4 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 2,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003460 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 27,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · derivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,890 Underlying: Common Stock · 27,890 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F7 · derivative.exercise_date: The restricted stock unit vests in two equal annual installments beginning March 1, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in two equal annual installments beginning March 1, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 50,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · derivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,333 Underlying: Common Stock · 50,333 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · derivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,561 Underlying: Common Stock · 13,281 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 13,060 | $67.55 | $882,203.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617,884 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
GrantCommon Stock | 13,944 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630,944 F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 13,281 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,844 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · derivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,361 Underlying: Common Stock · 1,844 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested or will vest in 30 equal monthly installments thereafter. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 28,156 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · derivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,156 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
SaleCommon Stock | 30,000 | $69.68 | $2,090,400.00 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,719 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $68.96 to $70.01. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,844 | $1.67 | $3,079.48 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 28,156 | $1.07 | $30,126.92 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 20:27 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,285 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-002133 · edgar.xml · derivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,253 Underlying: Common Stock · 1,285 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 20:27 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 1,285 | $67.21 | $86,364.85 |
DisclosureSEC source: 0001179110-19-002133 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,471 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 14, 2018. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 20:27 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,285 | $35.45 | $45,553.25 |
DisclosureSEC source: 0001179110-19-002133 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,168 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 914 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,876 Underlying: Common Stock · 914 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 455 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823 Underlying: Common Stock · 455 shares Expires 2025-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,734 Underlying: Common Stock · 2,734 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
SaleCommon Stock | 5,550 | $61.69 | $342,379.50 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 914 | $12.21 | $11,159.94 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 455 | $9.60 | $4,368.00 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:04 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 2,734 | $8.71 | $23,813.14 |
DisclosureSEC source: 0001179110-19-001744 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-19-000877 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,156 Underlying: Common Stock · 30,000 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
SaleCommon Stock | 30,000 | $63.04 | $1,891,200.00 |
DisclosureSEC source: 0001179110-19-000877 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,719 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $61.56 to $64.22. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 30,000 | $1.07 | $32,100.00 |
DisclosureSEC source: 0001179110-19-000877 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:05 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,284 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-000826 · edgar.xml · derivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,538 Underlying: Common Stock · 1,284 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.